
Moderna Inc said on Sunday it has received an additional US$472 million from the U.S. government’s Biomedical Advanced Research and Development Authority (BARDA) to support development of its novel coronavirus vaccine.


Moderna Inc said on Sunday it has received an additional US$472 million from the U.S. government’s Biomedical Advanced Research and Development Authority (BARDA) to support development of its novel coronavirus vaccine.